Barbara Schulz

754 total citations
22 papers, 516 citations indexed

About

Barbara Schulz is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Barbara Schulz has authored 22 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 10 papers in Immunology and 6 papers in Hematology. Recurrent topics in Barbara Schulz's work include Spondyloarthritis Studies and Treatments (12 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Barbara Schulz is often cited by papers focused on Spondyloarthritis Studies and Treatments (12 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). Barbara Schulz collaborates with scholars based in Germany, Switzerland and United Kingdom. Barbara Schulz's co-authors include Effie Pournara, Claudia Nicolay, H. Lorenz‐Meyer, V. Pudel, J Purrmann, Christian Scheurlen, Lisa Carr, Wolfgang E. Fleig, Irmtraut Koop and Peter Bauer and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Barbara Schulz

21 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Schulz Germany 9 228 162 106 98 86 22 516
Direkrit Chiewchengchol Thailand 16 217 1.0× 99 0.6× 45 0.4× 29 0.3× 48 0.6× 30 481
Susanne Loeliger Switzerland 7 368 1.6× 84 0.5× 26 0.2× 26 0.3× 74 0.9× 10 724
Aytül Sin Türkiye 15 167 0.7× 130 0.8× 29 0.3× 25 0.3× 29 0.3× 53 604
Abdullah Alangari Saudi Arabia 12 570 2.5× 72 0.4× 200 1.9× 214 2.2× 65 0.8× 30 927
Zahra Chavoshzadeh Iran 17 530 2.3× 41 0.3× 324 3.1× 112 1.1× 99 1.2× 95 908
Tolga Barker United States 13 485 2.1× 164 1.0× 32 0.3× 28 0.3× 153 1.8× 16 746
Xuefen Wu China 11 99 0.4× 88 0.5× 14 0.1× 40 0.4× 34 0.4× 19 413
Esra Adışen Türkiye 16 196 0.9× 81 0.5× 33 0.3× 20 0.2× 192 2.2× 73 711
R. Wigand Germany 11 152 0.7× 107 0.7× 116 1.1× 68 0.7× 58 0.7× 32 474
Chris Stevens United States 8 131 0.6× 46 0.3× 174 1.6× 34 0.3× 138 1.6× 10 538

Countries citing papers authored by Barbara Schulz

Since Specialization
Citations

This map shows the geographic impact of Barbara Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Schulz more than expected).

Fields of papers citing papers by Barbara Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Schulz. The network helps show where Barbara Schulz may publish in the future.

Co-authorship network of co-authors of Barbara Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Schulz. A scholar is included among the top collaborators of Barbara Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Schulz. Barbara Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baraliakos, Xenofon, Effie Pournara, Laura C. Coates, et al.. (2023). Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort. Lara D. Veeken. 63(1). 85–92. 6 indexed citations
2.
Holstein, A., et al.. (2023). Gastrointestinal: Whipple's disease: Often taught but rarely seen and diagnosed late. Journal of Gastroenterology and Hepatology. 38(10). 1679–1679.
3.
Baraliakos, Xenofon, Effie Pournara, Laure Gossec, et al.. (2022). Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial. RMD Open. 8(2). e002303–e002303. 3 indexed citations
4.
Kiltz, Uta, Petros P. Sfikakis, Karl Gaffney, et al.. (2022). Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab. Rheumatology and Therapy. 9(4). 1129–1142. 8 indexed citations
5.
Poddubnyy, Denis, Effie Pournara, Asta Baranauskaitė, et al.. (2021). Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211051471–1759720X211051471. 5 indexed citations
6.
Baraliakos, Xenofon, Laure Gossec, Effie Pournara, et al.. (2021). P184 Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial. Lara D. Veeken. 60(Supplement_1). 1 indexed citations
7.
8.
Kiltz, Uta, Petros P. Sfikakis, Nicola Gullick, et al.. (2021). POS0234 SECUKINUMAB RETENTION AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: 2 YEAR INTERIM RESULTS OF THE OBSERVATIONAL SERENA STUDY. Annals of the Rheumatic Diseases. 80. 337–338. 2 indexed citations
9.
Baraliakos, Xenofon, Laure Gossec, Effie Pournara, et al.. (2020). Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial. Annals of the Rheumatic Diseases. 80(5). 582–590. 110 indexed citations
10.
Poddubnyy, Denis, Effie Pournara, Agnieszka Zielińska, et al.. (2020). AB0659 SECUKINUMAB PROVIDES SIGNIFICANT IMPROVEMENT OF SPINAL PAIN IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE 24-WEEK PHASE 3 SKIPPAIN STUDY. Annals of the Rheumatic Diseases. 79. 1624–1625. 1 indexed citations
11.
Baraliakos, Xenofon, Laure Gossec, Effie Pournara, et al.. (2020). OP0053 SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL. Annals of the Rheumatic Diseases. 79. 35–36. 7 indexed citations
12.
Franz, Steffen, Barbara Schulz, Haili Wang, et al.. (2019). Management of pain in individuals with spinal cord injury: Guideline of the German-Speaking Medical Society for Spinal Cord Injury. SHILAP Revista de lepidopterología. 17. Doc05–Doc05. 20 indexed citations
13.
Baraliakos, Xenofon, Laura C. Coates, Laure Gossec, et al.. (2019). OP0235 SECUKINUMAB IMPROVES AXIAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NSAIDS: PRIMARY ANALYSIS OF THE MAXIMISE TRIAL. Annals of the Rheumatic Diseases. 78. 195–196. 19 indexed citations
14.
Schulz, Barbara, Stefan Zauscher, Hermann Ammer, Carola Sauter‐Louis, & Katrin Hartmann. (2013). Side effects suspected to be related to doxycycline use in cats. Veterinary Record. 172(7). 184–184. 6 indexed citations
15.
Schulz, Barbara, et al.. (2011). Suspected side effects of doxycycline use in dogs – a retrospective study of 386 cases. Veterinary Record. 169(9). 229–229. 26 indexed citations
16.
Adamik, Katja‐Nicole, et al.. (2010). Ileocolic intestinal intussusception in a dog with leptospirosis. Tierärztliche Praxis Ausgabe K Kleintiere / Heimtiere. 38(6). 403–405. 3 indexed citations
17.
18.
Schulz, Barbara, et al.. (2006). Psychotraumatologische Versorgung im bg-lichen Heilverfahren. Trauma und Berufskrankheit. 9(S01). S109–S112. 3 indexed citations
19.
Lorenz‐Meyer, H., Peter Bauer, Claudia Nicolay, et al.. (1996). Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial. Scandinavian Journal of Gastroenterology. 31(8). 778–785. 154 indexed citations
20.
Schulz, Barbara, G Michel, Stephan N. Wagner, et al.. (1993). Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.. The Journal of Immunology. 151(8). 4399–4406. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Direkrit Chiewchengchol Breakdown of academic impact, for papers by Susanne Loeliger Breakdown of academic impact, for papers by Aytül Sin Breakdown of academic impact, for papers by Abdullah Alangari Breakdown of academic impact, for papers by Zahra Chavoshzadeh Breakdown of academic impact, for papers by Tolga Barker Breakdown of academic impact, for papers by Xuefen Wu Breakdown of academic impact, for papers by Esra Adışen Breakdown of academic impact, for papers by R. Wigand Breakdown of academic impact, for papers by Chris Stevens
Rankless by CCL
2026